Search Orphan Drug Designations and Approvals
-
Generic Name: | tamibarotene |
---|---|
Date Designated: | 02/01/2022 |
Orphan Designation: | Treatment of Myelodysplastic Syndrome (MDS) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Syros Pharmaceuticals 35 Cambridgepark Drive Level 4 Cambridge, Massachusetts 02140 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-